On the other hand, in preterm infants, studies have linked a decrease in IGF1 to BPD, whereas treatment with rhIGF1/BP3 has been shown to improve lung growth in experimental BPD [13]. This evidence concerns the gene IGF1 and bronchopulmonary dysplasia.